Fitch Ratings Report Warns of Costly COVID-19 Aftermath for Payers, Patients, and Providers
Fitch Ratings released a report warning that the effects of the COVID-19 pandemic will be costly and possibly felt for [...]
95 Pharma-Backed Oncologists Support Woodcock for FDA Commissioner
Dr. Janet Woodcock has faced widespread criticism as news spread that she was being considered for Food and Drug Administration [...]
Understanding the Impact of COVID-19 on Pharma Market Trends and Costs
The COVID-19 pandemic is bringing about major changes to the healthcare and pharma industries. Managing Director of BioPharma Futures Mel [...]
Pfizer and BioNTech Raise Price of COVID-19 Vaccine as UK Orders Booster Shots, Pfizer’s 2021 Sales Hit $11.3 Billion
Pfizer and BioNTech announced a price increase for COVID-19 booster shots—from £18 to £22. The European Union and the United [...]
AbbVie HEOR Expert Notes Lack of Diversity Negatively Impacts Clinical Trials, RWD Offers Possible Solution
Vice President and Global Head of Health Economics and Outcomes Research (HEOR) at AbbVie Dr. Chris Boone notes that the [...]
COVID-19 Shakes Up Business, Prompts Employers to Consider Value-Based Care
The COVID-19 pandemic has accelerated the rise in healthcare costs. Now, employers are considering value-based care instead of traditional healthcare [...]
Data Analytics Highlight Delayed Pediatric Care During COVID-19 Pandemic and Inform Solutions
The Ann & Robert Lurie Children’s Hospital used analytics to understand how the COVID-19 pandemic was impacting patient care. Analytic [...]
Register Today for Next Week’s Webinar on Medical Cost Trends During and Post-Pandemic
A virtual event on medical cost trends will take place on Thursday, August 12th at 1:00 PM EST. Speakers will [...]
HealthVerity’s 76 RWD Sources Inform COVID-19 Booster Shot Discussion
In an effort to understand how variants respond to COVID-19 vaccines, researchers are turning to real world data (RWD), such [...]
JAMA Study Uses Population Health Data to Understand the Economic Impact of COVID-19
Researchers in Australia sought to understand the impact of COVID-19 using population health data. The article, published in the Journal [...]
New ISPOR Article Discusses Survey on the Impact of COVID-19 on HTAs and Payers
A new article, published in ISPOR’s Value in Health journal, discusses how the COVID-19 pandemic has impacted health technology assessments [...]
Widespread Price-Gouging of COVID-19 Tests Continues According to New AHIP Study
A recent study conducted by America’s Health Insurance Plans (AHIP) found that healthcare systems continue to up-charge for COVID-19 tests, [...]
I-MAK Co-Founder Discusses How the COVID-19 Pandemic Shed Light on Racial Inequities and Using the Patent System to Reduce Drug Prices
Co-Founder and Executive Director of the Initiative for Medicines, Access & Knowledge (I-MAK) Priti Krishtel shares her thoughts on how [...]
New Report Projects Global Digital Healthcare Market to Hit $456.9 Billion by 2026 as Patient RWD Continues to Grow
A recently published report estimates the global digital health market will reach $456.9 by 2026, largely due to widespread use [...]
Winners Announced for IMD’s Career Cluster Day Case Competition
Clinerion recently hosted a case competition highlighting the use of real world data (RWD) in healthcare. Students considered the many [...]
Report Highlights the Impact of the COVID-19 Pandemic on Healthcare Preferences
A new report features insight from a survey of 1,000 participants. Key trends include a shift to virtual care, online [...]
HealthVerity Discusses COVID-19, Booster Vaccines, and RWD
As variants of the COVID-19 virus emerge, included the concerning delta variant, pharmaceutical companies are suggesting that a booster shot [...]
Astellas US President Discusses Improving Medication Affordability, Patient-Centered Care, and Learning From COVID-19 Challenges
PhRMA board member and Astellas US President Mark Reisenauer shares his thoughts on improving the healthcare system in the United [...]
Prescription Drug Prices Increased 3.1% in July 2020 According to GoodRx
GoodRx found that 52 drugs rose in price by 3.1% in July 2020, while no generics upped their prices. Zogenix’s [...]
Vanderbilt and Stanford Professors Discuss 2021 Drug Pricing Reform in JAMA Article, Note Power of Value Assessments and Medicare Negotiation During COVID-19 Pandemic
Dr. Stacie Dusetzina of Vanderbilt University School of Medicine and Dr. Michelle Mello of Stanford Law School and Stanford School [...]
Despite WHO Recommendation, COVID-19 Drug Too Costly and Inaccessible; Will Roche Give Up Monopoly?
The World Health Organization (WHO) has recommended the use of monoclonal antibody tocilizumab in cases of severe COVID-19 illness. However, [...]
Register Today for IQVIA Webinar on Medicine Use in the United States During the COVID-19 Pandemic and Beyond
The IQVIA Institute will host a webinar to discuss its recent report on medicine use in the United States. The [...]
ICON Announces Acquisition of PRA Health Sciences
Healthcare intelligence company ICON has announced its plans to acquire PRA Health. The move is expected to provide immense value [...]
ISPOR President Reflects on COVID-19 Challenges and Lasting Achievements
President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Director and Partner at Boston Consulting Group Dr. [...]
Transitioning to Value-Based Care Requires Understanding Perceptions and Opening Up the Conversation to Diverse Stakeholders
Healthcare stakeholders hold different perceptions of value-based care, with some stakeholders associating “value” with sub-optimal care. A recent ISPOR article, [...]